Li, R., Sun, Y., Feng, M., Kelsang, D., Cai, H., Zhang, J. (2026). Isoliquiritigenin alleviates ulcerative colitis by enhancing the intestinal barrier and improving intestinal microbiota via inhibiting the TLR4/MyD88/NF-κB pathway. Scientific Reports. https://doi.org/10.1038/s41598-026-46594-8